Merit Medical Systems Cash on Hand 2012-2025 | MMSI

Merit Medical Systems cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Merit Medical Systems Annual Cash on Hand
(Millions of US $)
2024 $377
2023 $587
2022 $58
2021 $68
2020 $57
2019 $44
2018 $67
2017 $32
2016 $19
2015 $4
2014 $7
2013 $7
2012 $10
2011 $10
Merit Medical Systems Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $392
2025-06-30 $342
2025-03-31 $396
2024-12-31 $377
2024-09-30 $523
2024-06-30 $637
2024-03-31 $582
2023-12-31 $587
2023-09-30 $59
2023-06-30 $72
2023-03-31 $58
2022-12-31 $58
2022-09-30 $51
2022-06-30 $63
2022-03-31 $54
2021-12-31 $68
2021-09-30 $69
2021-06-30 $70
2021-03-31 $59
2020-12-31 $57
2020-09-30 $45
2020-06-30 $50
2020-03-31 $50
2019-12-31 $44
2019-09-30 $37
2019-06-30 $35
2019-03-31 $50
2018-12-31 $67
2018-09-30 $52
2018-06-30 $44
2018-03-31 $34
2017-12-31 $32
2017-09-30 $23
2017-06-30 $38
2017-03-31 $26
2016-12-31 $19
2016-09-30 $17
2016-06-30 $10
2016-03-31 $5
2015-12-31 $4
2015-09-30 $6
2015-06-30 $12
2015-03-31 $10
2014-12-31 $7
2014-09-30 $6
2014-06-30 $9
2014-03-31 $13
2013-12-31 $7
2013-09-30 $9
2013-06-30 $13
2013-03-31 $9
2012-12-31 $10
2012-09-30 $9
2012-06-30 $10
2012-03-31 $10
2011-12-31 $10
2011-09-30 $6
2011-06-30 $63
2011-03-31 $3
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.721B $1.357B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $117.318B 25.49
Becton Dickinson (BDX) United States $58.836B 14.32
Cardinal Health (CAH) United States $53.977B 23.64
West Pharmaceutical Services (WST) United States $16.664B 32.76
Cooper (COO) United States $15.698B 19.40
Align Technology (ALGN) United States $12.601B 21.39
Henry Schein (HSIC) United States $9.065B 15.98
DENTSPLY SIRONA (XRAY) United States $2.500B 7.93
CONMED (CNMD) United States $1.259B 8.82
STAAR Surgical (STAA) United States $0.849B 0.00
Pro-Dex (PDEX) United States $0.123B 14.68
Lifevantage (LFVN) United States $0.059B 6.08
Axe Compute (AGPU) United States $0.008B 0.00